Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.37 |
| ▸ | ADH1B | P00325 | 1/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | ADH4 | P08319 | 1/20 | 0.33 |
| ▸ | ADH7 | P40394 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5493445 | 0.98 | EPHX1 (0.41) | ALDH1A1TSHREPHX1ADH1BADH1C | |
| SCHEMBL9244557 | 0.98 | EPHX1 (0.41) | ALDH1A1TSHREPHX1ADH1BADH1C | |
| SCHEMBL27515295 | 0.98 | EPHX1 (0.41) | ALDH1A1TSHREPHX1ADH1BADH1C | |
| SCHEMBL27621804 | 0.98 | EPHX1 (0.41) | ALDH1A1TSHREPHX1ADH1BADH1C | |
| SCHEMBL28988992 | 0.98 | EPHX1 (0.41) | ALDH1A1TSHREPHX1ADH1BADH1C | |
| SCHEMBL27497465 | 0.98 | EPHX1 (0.41) | ALDH1A1TSHREPHX1ADH1BADH1C | |
| SCHEMBL27499290 | 0.98 | EPHX1 (0.41) | ALDH1A1TSHREPHX1ADH1BADH1C | |
| SCHEMBL9407143 | 0.84 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL29234732 | 0.80 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL27446710 | 0.79 | ALDH1A1 (0.42) | ALDH1A1TSHREPHX1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0405986-A2 | method of processing presensitized lithographic printing plate | KONICA CORPORATION (JP) | 1991-01-02 | — | — | EP | claimed |
| CN-118340726-A | Aqueous suspension composition containing sirolimus or salt thereof | 参天制药株式会社 | 2024-07-16 | — | — | CN | disclosed |
| WO-2024135837-A1 | EPINASTINE-CONTAINING AQUEOUS COMPOSITION FOR IMPROVING TISSUE TRANSFERABILITY AND PRESERVATIVE EFFECT | 参天製薬株式会社 | 2024-06-27 | — | — | WO | disclosed |
| CN-114845714-B | Aqueous suspension composition containing sirolimus or salt thereof | 参天制药株式会社 | 2024-05-14 | — | — | CN | disclosed |
| CN-117752662-A | Formulations of 4- (7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl) -benzonitrile | 博士伦爱尔兰有限公司 | 2024-03-26 | — | — | CN | disclosed |
| WO-2023223993-A1 | COMPOSITION FOR TREATING RINGWORM | マルホ株式会社 | 2023-11-23 | — | — | WO | disclosed |
| WO-2023204297-A1 | COMPOSITION FOR OPHTHALMIC USE CONTAINING SEPETAPROST | 参天製薬株式会社 | 2023-10-26 | — | — | WO | disclosed |
| CN-116744904-A | Pharmaceutical composition for transdermal administration comprising epinastine or a salt thereof and a thio-antioxidant | 参天制药株式会社 | 2023-09-12 | — | — | CN | disclosed |
| CN-111568906-B | Formulations of 4- (7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl) -benzonitrile | 诺华股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116669705-A | Pharmaceutical composition for coating administration containing epinastine or salt thereof | 参天制药株式会社 | 2023-08-29 | — | — | CN | disclosed |
| CN-1929864-A | Composite particle and coated composite particle | KYOWA HAKKO KOGYO KK (JP) | 2007-03-14 | — | — | CN | disclosed |
| US-20060018867-A1 | Cosmetic composition and production thereof | ICHIMARU PHARCOS CO., LTD | 2006-01-26 | — | — | US | disclosed |
| EP-1604647-A1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | Ichimaru Pharcos Co., Ltd. (JP) | 2005-12-14 | — | — | EP | disclosed |
| EP-0490515-B1 | Method for preparing lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 1997-10-15 | — | — | EP | disclosed |
| EP-0484087-B1 | Method and apparatus for processing presensitized lithographic printing plate | KONISHIROKU PHOTO IND (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5480762-A | Method for preparing lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1996-01-02 | — | — | US | disclosed |
| US-5217848-A | METHOD AND APPARATUS FOR PROCESSING PRESENSITIZED LITHOGRAPHIC PRINTING PLATE | KONICA CORPORATION (JP) | 1993-06-08 | — | — | US | disclosed |
| EP-0490515-A1 | Method for preparing lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1992-06-17 | — | — | EP | disclosed |
| EP-0484087-A2 | Method and apparatus for processing presensitized lithographic printing plate | KONICA CORPORATION (JP) | 1992-05-06 | — | — | EP | disclosed |
| EP-0405986-A2 | method of processing presensitized lithographic printing plate | KONICA CORPORATION (JP) | 1991-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018867-A1 | Cosmetic composition and production thereof | CUTA, PARG, TYR | ALDH1A1 1854/4885TSHR 3312/4885EPHX1 2769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.